Reduction of Dopamine Synaptic Activity: Degradation of 50-kHz Ultrasonic Vocalization in Rats

Behavioral Neuroscience

Volumn 123, Issue 2, 2009, Pages 328-336

  Ciucci, Michelle R ^a   Ahrens, Allison M ^a   Ma, Sean T ^a   Kane, Jacqueline R ^a   Windham, E Blake ^a   Woodlee, Martin T ^a   Schallert, Timothy ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

dopamine; Parkinson's disease; rat; speech; ultrasonic vocalization

Indexed keywords

DOPAMINE; HALOPERIDOL; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; FEMALE; FREQUENCY ANALYSIS; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; PARKINSON DISEASE; RAT; SOUND INTENSITY; SYNAPSE; VOCALIZATION;

ANALYSIS OF VARIANCE; ANIMALS; CHLOROQUINOLINOLS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HALOPERIDOL; MALE; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, LONG-EVANS; SYNAPSES; ULTRASONICS; VOCALIZATION, ANIMAL;

EID: 65249138743     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0014593     Document Type: Article

References (51)

1. Ahrens, A. M., Ma, S. T., Maier, E. Y., Duvauchelle, C. L., & Schallert, T. (in press). Repeated intravenous amphetamine exposure: Rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats. Behavioural Brain Research
2. Baker K.K., Ramig L.O., Luschei E.S., and Smith M.E. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology 51 (1998) 1592-1598
3. Bejjani B.P., Damier P., Arnulf I., Thivard L., Bonnet A.M., Dormont D., et al. Transient acute depression induced by high-frequency deep-brain stimulation. New England Journal of Medicine 340 (1999) 1476-1480
4. Bialy M., Rydz M., and Kaczmarek L. Procontact 50-kHz vocalizations in male rats during acquisition of sexual experience. Behavioral Neuroscience 114 (2000) 983-990
5. Blanchard R.J., Agullana R., McGee L., Weiss S., and Blanchard D.C. Sex differences in the incidence and sonographic characteristics of antipredator ultrasonic cries in the laboratory rat (Rattus norvegicus). Journal of Comparative Psychology 106 (1992) 270-277
6. Braak H., Rüb U., Gai W.P., and Del Tredici K. Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission 110 (2003) 517-536
7. Brown R.G., Dowsey P.L., Brown P., Jahanshahi M., Pollak P., Benabid A.L., et al. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Annals of Neurology 45 (1999) 473-488
8. Brudzynski S.M. Principles of rat communication: Quantitative parameters of ultrasonic calls in rats. Behavior Genetics 35 (2005) 85-92
9. Brudzynski S.M., Bihari F., Ociepa D., and Fu X.W. Analysis of 22 kHz ultrasonic vocalization in laboratory rats: Long and short calls. Physiology and Behavior 54 (1993) 215-221
10. Brudzynski S.M., and Ociepa D. Ultrasonic vocalization of laboratory rats in response to handling and touch. Physiology and Behavior 52 (1992) 655-660
11. Brudzynski S.M., and Pniak A. Social contacts and production of 50-kHz short ultrasonic calls in adult rats. Journal of Comparative Psychology 116 (2002) 73-82
12. Burgdorf J., Wood P.L., Kroes R.A., Moskal K.R., and Panksepp J. The neurobiology of 50-kHz ultrasonic vocalizations of rats: Electrode mapping, lesion, and pharmacology studies. Behavioural Brain Research 18 2 (2007) 274-283
13. Carella F., Genitrini S., Bressanelli M., Soliveri P., Servello D., Broggi G., et al. Acute effects of bilateral subthalamic nucleus stimulation on clinical and kinematic parameters in Parkinson's disease. Movement Disorders 16 (2001) 651-655
14. Ciucci M.R., Ma S.T., Fox C., Kane J.R., Ramig L.O., and Schallert T. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: A preliminary study. Behavioral Brain Research 182 (2007) 284-289
15. Ciucci M.R., Ma S.T., Kane J.R., Ahrens A.M., and Schallert T. Limb-use and complex ultrasonic vocalization in a rat model of Parkinson's disease: Deficit targeted training. Parkinsonism and Related Disorders 14 (2008) S172-S175
16. Darley F.L., Aronson A.E., and Brown J.R. Differential diagnostic patterns of dysarthria. Journal of Speech and Hearing Research 12 (1969) 246-269
17. Darley F.L., Aronson A.E., and Brown J.R. Clusters of deviant speech dimensions in dysarthrias. Journal of Speech and Hearing Research 12 (1969) 462-496
18. DeLetter M., Santens P., DeBodt M., Boon P., and VanBorsel J. Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurologica Belgica 106 (2006) 19-22
19. D'Alatri L., Paludetti G., Contarino M.F., Galla S., Marchese M.R., and Bentivoglio A.R. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. Journal of Voice 22 (2008) 365-372
20. Dromey C., Kumar R., Lang A.E., and Lozano A.M. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Movement Disorders 15 (2000) 1132-1138
21. Fox C.M., Morrison C.E., Ramig L.O., and Sapir S. Current perspectives on the Lee Silverman voice treatment (LSVT) for individuals with idiopathic Parkinson disease. American Journal of Speech-Language Pathology 27 (2002) 309-319
22. Fu X.W., and Brudzynski S.M. High-frequency ultrasonic vocalization induced by intracerebral glutamate in rats. Pharmacology, Biochemistry, and Behavior 49 (1994) 835-841
23. Fulceri F., Biagioni F., Lenzi P., Falleni A., Gesi M., Ruggieri S., et al. Nigrostriatal damage with 6-OHDA: Validation of routinely applied procedures. Annals of the New York Academy of Science 1074 (2006) 344-348
24. Gallena S., Smith P.J., Zeffiro T., and Ludlow C.L. Effects of levodopa on laryngeal muscle activity for voice onset in Parkinson disease. Journal of Speech, Language, and Hearing Research 44 (2001) 1284-1299
25. Goberman A.M., and Blomgren M. Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease. Journal of Voice 22 (2008) 178-191
26. Goberman A.M., Coelho C., and Robb M. Phonatory characteristics of parkinsonian speech before and after morning medication: The ON and OFF states. Journal of Communication Disorders 35 (2002) 217-239
27. Hanson D.G., Gerratt B.R., and Ward P.H. Cinegraphic observations of laryngeal function in Parkinson's disease. Laryngoscope 94 (1984) 348-353
28. Hartelius L., and Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: A survey. Folia Phoniatrica Logopaedica 46 (1994) 9-17
29. Herrera-Marschitz M., Casas M., and Ungerstedt U. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: Comparisons with apomorphine-induced responses. Psychopharmacology 94 (1988) 38-45
30. Ho A.K., Iansek R., Marigliani C., Bradshaw J.L., and Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behavioural Neurology 11 (1998) 131-137
31. Jiang J., Lin E., Wang J., and Hanson D.G. Glottographic measures before and after levodopa treatment in Parkinson's disease. Laryngoscope 109 (1999) 1287-1294
32. Klostermann F., Ehlen F., Vesper J., Nubel K., Gross M., Marzinzik F., et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 79 (2008) 522-529
33. Logemann J.A., Fisher H.B., Boshes B., and Blonsky E.R. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech Hearing and Disorders 43 (1978) 47-57
34. Marshall J.F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control. Brain Research 177 (1979) 311-324
35. McGinnis M.Y., and Vakulenko M. Characterization of 50-kHz ultrasonic vocalizations in male and female rats. Physiology & Behavior 20 (2003) 81-88
36. McRae P.A., Tjaden K., and Schoonings B. Acoustic and perceptual consequences of articulatory rate change in Parkinson disease. Journal of Speech, Language, and Hearing Research 45 (2002) 35-50
37. Pinto S., Ozsancak C., Tripoliti E., Thobois S., Limousin-Dowsey P., and Auzoum P. Treatments for dysarthria in Parkinson's disease. Lancet Neurology 3 (2004) 547-556
38. Ramig L.O., Gray S., Baker K., Corbin-Lewis K., Buder E., Luschei E., et al. The aging voice: A review, treatment data and familial and genetic perspectives. Folia Phoniatrica Logopaedica 53 (2001) 252-265
39. Ramig L.O., Sapir S., Countryman S., Pawlas A.A., O'Brien C., Hoehn M., et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: A 2 year follow up. Journal of Neurology, Neurosurgery and Psychiatry 71 (2001) 493-498
40. Roberts L.H. The rodent ultrasound production mechanism. Ultrasonics 13 (1975) 83-85
41. Sanabria J., Ruiz P.G., Gutierrez R., Marquez R., Marquez F., Escobar P., et al. The effect of levodopa on vocal function in Parkinson's disease. Clinical Neuropharmacology 24 (2001) 99-102
42. Sanders I., Weisz D.J., Yang B.Y., Fung K., and Amirali A. The mechanism of ultrasonic vocalization in the rat. Society of Neuroscience Abstracts 27 (2001) 19
43. Sapir S., Ramig L.O., and Fox C. The Lee Silverman voice treatment (LSVT) for voice, speech, and other orofacial disorders in people with Parkinson's disease. Future Neurology 1 (2006) 563-570
44. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral models of stroke, cortical ablation, Parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
45. Schallert T., and Tillerson J.L. Intervention strategies for degeneration of dopamine neurons in Parkinsonism: Optimizing behavioral assessment of outcome. In: Emerich D.F., Dean R.L., and Sanberg P.R. (Eds). Central nervous system diseases: Innovative models of CNS diseases from molecule to therapy (2000), Humana, Totowa, NJ 131-151
46. Schallert T., and Woodlee M.T. Motor systems: Orienting and placing. In: Whishaw I.Q., and Kolb B. (Eds). The behavior of the laboratory rat: A hand book with tests (2005), Oxford University Press, New York 129-140
47. Solomon N.P., Robin D.A., and Luschei E.S. Strength, endurance, and stability of the tongue and hand in Parkinson disease. Journal of Speech, Language, and Hearing Research 43 (2000) 256-267
48. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., and Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. Journal of Neuroscience 21 (2001) 4427-4435
49. Ungerstedt U., and Arbuthnott G. Quantitative recording of rotational behavior in rats after 6-OHDA lesions of the nigrostriatal dopamine system. Brain Research 24 (1970) 485-493
50. Wintink A.J., and Brudzynski S.M. The related roles of dopamine and glutamate in the initiation of 50-kHz ultrasonic calls in adult rats. Pharmacology, Biochemistry, and Behavior 70 (2001) 317-323
51. Wöhr M., Houx B., Schwarting R.K., and Spruijt B. Effects of experience and context on 50-kHz vocalizations in rats. Physiology and Behavior 93 (2007) 766-776